|
|
 |
EECP® | | | General Information | |
| Vendor | | Vasomedical | | Item | | EECP® | | Features | | Augmented diastolic pressure and retrograde aortic flow increase myocardial perfusion
Systolic unloading reduces cardiac workload and oxygen requirements
Increased venous return, coupled with enhanced systolic flow, increases cardiac output | | Regulatory Approval | | US FDA | | Supportive Clinical Trial Data | | yes | | Pricing |  | Inquire | | Financing | | To finance this purchase click here (U.S. customers only) |
| | Product Description | |
| EECP therapy extends the ability of interventional cardiologists and cardiothoracic surgeons to treat coronary artery disease, and provides non-interventional cardiologists with a means of participating in the treatment of patients who have become refractory to drugs. Vasomedical's EECP therapy provides a noninvasive, atraumatic treatment for coronary artery disease, and offers new hope to patients who are poor candidates for other invasive measures. Data from Vasomedical’s EECP sponsored registries and studies and general clinical experience have shown that nearly 80% of treated patients achieve significant benefits from 35, 1-hour treatment sessions. | |
| Vasomedical | | Customer Service: (800) 455-3327 | | Web site: http://www.vasomedical.com/ | |
| NOTE: Medcompare disclaims any information on this site. The information found on Medcompare (Drug Guide, Product Listings and otherwise) is intended for use by medical professionals. This information is not intended to replace the information, advice or instructions from a medical doctor. Pricing information is approximate, actual prices may vary. |
|
|
